Targeting GM-CSF in COVID-19 Pneumonia: Rationale and Strategies

COVID-19 is a clinical syndrome ranging from mild symptoms to severe pneumonia that often leads to respiratory failure, need for mechanical ventilation, and death. Most of the lung damage is driven by a surge in inflammatory cytokines [interleukin-6, interferon-γ, and granulocyte-monocyte stimulatin...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Front Immunol
Autores principales: Bonaventura, Aldo, Vecchié, Alessandra, Wang, Tisha S., Lee, Elinor, Cremer, Paul C., Carey, Brenna, Rajendram, Prabalini, Hudock, Kristin M., Korbee, Leslie, Van Tassell, Benjamin W., Dagna, Lorenzo, Abbate, Antonio
Formato: Artigo
Lenguaje:Inglês
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7348297/
https://ncbi.nlm.nih.gov/pubmed/32719685
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.01625
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares